{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,21]],"date-time":"2026-10-21T21:01:23Z","timestamp":1792616483068,"version":"4.5.0"},"reference-count":51,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2026,8,1]],"date-time":"2026-08-01T00:00:00Z","timestamp":1785542400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,8,1]],"date-time":"2026-08-01T00:00:00Z","timestamp":1785542400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2026,8,11]],"date-time":"2026-08-11T00:00:00Z","timestamp":1786406400000},"content-version":"vor","delay-in-days":10,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100000268","name":"Biotechnology and Biological Sciences Research Council","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100000268","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100010269","name":"Wellcome Trust","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100010269","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100000770","name":"University of Manchester","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100000770","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100000265","name":"UKRI Medical Research Council","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100000265","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["cell.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Molecular Therapy"],"published-print":{"date-parts":[[2026,8]]},"DOI":"10.1016\/j.ymthe.2026.08.004","type":"journal-article","created":{"date-parts":[[2026,8,10]],"date-time":"2026-08-10T15:44:15Z","timestamp":1786376655000},"update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":1,"title":["Human iPSC-derived neural progenitor gene therapy improves outcomes in a neuropathic lysosomal disease"],"prefix":"10.1016","author":[{"given":"Oriana","family":"Mandolfo","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yuko Ishikawa","family":"Learmonth","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Asma\u2019u","family":"Usman","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Maryann","family":"Lorino","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tereza","family":"Andreou","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rebecca","family":"Holley","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bei","family":"Qiu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tristan","family":"Mckay","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-9708-1112","authenticated-orcid":false,"given":"Brian W.","family":"Bigger","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.ymthe.2026.08.004_bib1","doi-asserted-by":"crossref","first-page":"876","DOI":"10.1002\/ana.22092","article-title":"Mucopolysaccharidosis type IIIA: Clinical spectrum and genotype-phenotype correlations","volume":"68","author":"Valstar","year":"2010","journal-title":"Ann. Neurol."},{"key":"10.1016\/j.ymthe.2026.08.004_bib2","doi-asserted-by":"crossref","first-page":"v4","DOI":"10.1093\/rheumatology\/ker394","article-title":"Overview of the mucopolysaccharidoses","volume":"50","author":"Muenzer","year":"2011","journal-title":"Rheumatology"},{"key":"10.1016\/j.ymthe.2026.08.004_bib3","doi-asserted-by":"crossref","first-page":"462","DOI":"10.1111\/apa.12169","article-title":"Mucopolysaccharidosis type III (Sanfilippo syndrome) and misdiagnosis of idiopathic developmental delay, attention deficit\/hyperactivity disorder or autism spectrum disorder","volume":"102","author":"Wijburg","year":"2013","journal-title":"Acta Paediatr."},{"key":"10.1016\/j.ymthe.2026.08.004_bib4","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1007\/s11011-017-0111-4","article-title":"How close are we to therapies for Sanfilippo disease?","volume":"33","author":"Gaffke","year":"2018","journal-title":"Metab. Brain Dis."},{"key":"10.1016\/j.ymthe.2026.08.004_bib5","doi-asserted-by":"crossref","DOI":"10.1186\/s13052-018-0565-y","article-title":"Gene therapy for mucopolysaccharidoses: in vivo and ex vivo approaches","volume":"44","author":"Fraldi","year":"2018","journal-title":"Ital. J. Pediatr."},{"key":"10.1016\/j.ymthe.2026.08.004_bib6","first-page":"S176","article-title":"Poor cognitive outcome of eleven children with Sanfilippo syndrome after bone marrow transplantation and successful engraftment","volume":"15","author":"Klein","year":"1995","journal-title":"Bone Marrow Transplant."},{"key":"10.1016\/j.ymthe.2026.08.004_bib7","doi-asserted-by":"crossref","first-page":"1938","DOI":"10.1038\/mt.2013.141","article-title":"Myeloid\/Microglial Driven Autologous Hematopoietic Stem Cell Gene Therapy Corrects a Neuronopathic Lysosomal Disease","volume":"21","author":"Sergijenko","year":"2013","journal-title":"Mol. Ther."},{"key":"10.1016\/j.ymthe.2026.08.004_bib8","doi-asserted-by":"crossref","first-page":"1897","DOI":"10.1182\/blood-2022-168672","article-title":"Biochemical Engraftment and Clinical Outcomes Following Ex-Vivo Autologous Stem Cell Gene Therapy for Mucopolysaccharidosis Type IIIA","volume":"140","author":"Wynn","year":"2022","journal-title":"Blood"},{"key":"10.1016\/j.ymthe.2026.08.004_bib9","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.ymgme.2017.08.009","article-title":"Developmental and behavioral aspects of mucopolysaccharidoses with brain manifestations - Neurological signs and symptoms","volume":"122S","author":"Shapiro","year":"2017","journal-title":"Mol. Genet. Metab."},{"key":"10.1016\/j.ymthe.2026.08.004_bib10","doi-asserted-by":"crossref","first-page":"213","DOI":"10.1212\/WNL.98.18_supplement.213","article-title":"Updated results of Transpher A, a multicenter, single-dose, Phase 1\/2 clinical trial of ABO-102 investigational gene therapy for Sanfilippo syndrome type A (mucopolysaccharidosis IIIA) (S39.008)","volume":"98","author":"Flanigan","year":"2022","journal-title":"Neurology"},{"key":"10.1016\/j.ymthe.2026.08.004_bib11","first-page":"643","article-title":"Central nervous system stem cell transplantation for children with neuronal ceroid lipofuscinosis","volume":"11","author":"Selden","year":"2013","journal-title":"J. Neurosurg."},{"key":"10.1016\/j.ymthe.2026.08.004_bib12","doi-asserted-by":"crossref","first-page":"17","DOI":"10.1186\/s12967-014-0371-2","article-title":"Human neural stem cell transplantation in ALS: initial results from a phase I trial","volume":"13","author":"Mazzini","year":"2015","journal-title":"J. Transl. Med."},{"key":"10.1016\/j.ymthe.2026.08.004_bib13","doi-asserted-by":"crossref","first-page":"127","DOI":"10.1016\/bs.mcb.2022.04.007","article-title":"Intracerebroventricular transplantation of human iPSC-derived neural stem cells (hiPSC-NSCs) into neonatal mice","volume":"171","author":"Luciani","year":"2022","journal-title":"Methods Cell Biol."},{"key":"10.1016\/j.ymthe.2026.08.004_bib14","doi-asserted-by":"crossref","first-page":"1954","DOI":"10.4103\/1673-5374.367845","article-title":"Gene-modified neural progenitor cells for the treatment of neuropathic lysosomal storage diseases","volume":"18","author":"Mandolfo","year":"2023","journal-title":"Neural Regen. Res."},{"key":"10.1016\/j.ymthe.2026.08.004_bib15","doi-asserted-by":"crossref","first-page":"113","DOI":"10.1016\/j.omtm.2018.06.005","article-title":"Genetically Corrected iPSC-Derived Neural Stem Cell Grafts Deliver Enzyme Replacement to Affect CNS Disease in Sanfilippo B Mice","volume":"10","author":"Clarke","year":"2018","journal-title":"Mol. Ther. Methods Clin. Dev."},{"key":"10.1016\/j.ymthe.2026.08.004_bib16","doi-asserted-by":"crossref","first-page":"452","DOI":"10.1016\/j.omtm.2022.10.013","article-title":"Brain transplantation of genetically corrected Sanfilippo type B neural stem cells induces partial cross-correction of the disease","volume":"27","author":"Pearse","year":"2022","journal-title":"Mol. Ther. Methods Clin. Dev."},{"key":"10.1016\/j.ymthe.2026.08.004_bib17","doi-asserted-by":"crossref","DOI":"10.1016\/j.ymgme.2024.108533","article-title":"Generation of a novel immunodeficient mouse model of Mucopolysaccharidosis type IIIA to test human stem cell-based therapies","volume":"143","author":"Mandolfo","year":"2024","journal-title":"Mol. Genet. Metab."},{"key":"10.1016\/j.ymthe.2026.08.004_bib18","doi-asserted-by":"crossref","first-page":"835","DOI":"10.1016\/j.stemcr.2015.02.022","article-title":"Ex Vivo Gene Therapy Using Patient iPSC-Derived NSCs Reverses Pathology in the Brain of a Homologous Mouse Model","volume":"4","author":"Griffin","year":"2015","journal-title":"Stem Cell Rep."},{"key":"10.1016\/j.ymthe.2026.08.004_bib20","doi-asserted-by":"crossref","first-page":"3175","DOI":"10.1182\/blood-2001-12-0207","article-title":"NOD\/SCID\/gamma(c)(null) mouse: an excellent recipient mouse model for engraftment of human cells","volume":"100","author":"Ito","year":"2002","journal-title":"Blood"},{"key":"10.1016\/j.ymthe.2026.08.004_bib21","doi-asserted-by":"crossref","first-page":"352","DOI":"10.5966\/sctm.2015-0414","article-title":"Generation of Human Induced Pluripotent Stem Cell-Derived Bona Fide Neural Stem Cells for Ex Vivo Gene Therapy of Metachromatic Leukodystrophy","volume":"6","author":"Meneghini","year":"2017","journal-title":"Stem Cells Transl. Med."},{"key":"10.1016\/j.ymthe.2026.08.004_bib22","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0035787","article-title":"Neuropathology in Mouse Models of Mucopolysaccharidosis Type I, IIIA and IIIB","volume":"7","author":"Wilkinson","year":"2012","journal-title":"PLoS ONE"},{"key":"10.1016\/j.ymthe.2026.08.004_bib23","doi-asserted-by":"crossref","first-page":"942","DOI":"10.1038\/nn.4043","article-title":"Diversity of astrocyte functions and phenotypes in neural circuits","volume":"18","author":"Khakh","year":"2015","journal-title":"Nat. Neurosci."},{"key":"10.1016\/j.ymthe.2026.08.004_bib24","first-page":"1109","article-title":"Alkaline Phosphatase-Positive Colony Formation Is a Sensitive, Specific, and Quantitative Indicator of Undifferentiated Human Embryonic Stem Cells","volume":"26","author":"O'Connor","year":"2008","journal-title":"Int. J. Cel. Cloning"},{"key":"10.1016\/j.ymthe.2026.08.004_bib25","doi-asserted-by":"crossref","DOI":"10.1016\/j.yexcr.2021.112785","article-title":"Disease modeling for Mucopolysaccharidosis type IIIB using patient derived induced pluripotent stem cells","volume":"407","author":"Huang","year":"2021","journal-title":"Exp. Cell Res."},{"key":"10.1016\/j.ymthe.2026.08.004_bib26","article-title":"Mature neurons from iPSCs unveil neurodegeneration-related pathways in mucopolysaccharidosis type II: GSK-3\u03b2 inhibition for therapeutic potential","volume":"15","author":"Chen","year":"2024","journal-title":"Cell Death Dis."},{"key":"10.1016\/j.ymthe.2026.08.004_bib27","doi-asserted-by":"crossref","first-page":"39","DOI":"10.1186\/scrt39","article-title":"Role of Oct4 in maintaining and regaining stem cell pluripotency","volume":"1","author":"Shi","year":"2010","journal-title":"Stem Cell Res. Ther."},{"key":"10.1016\/j.ymthe.2026.08.004_bib28","doi-asserted-by":"crossref","first-page":"411","DOI":"10.1016\/j.cell.2009.01.023","article-title":"Oct4-Induced Pluripotency in Adult Neural Stem Cells","volume":"136","author":"Kim","year":"2009","journal-title":"Cell"},{"key":"10.1016\/j.ymthe.2026.08.004_bib29","article-title":"Impaired neural differentiation of MPS IIIA patient induced pluripotent stem cell-derived neural progenitor cells","volume":"29","author":"Lehmann","year":"2021","journal-title":"Mol. Genet. Metab. Rep."},{"key":"10.1016\/j.ymthe.2026.08.004_bib30","doi-asserted-by":"crossref","first-page":"1610","DOI":"10.1038\/mt.2012.82","article-title":"Hematopoietic Stem Cell and Gene Therapy Corrects Primary Neuropathology and Behavior in Mucopolysaccharidosis IIIA Mice","volume":"20","author":"Langford-Smith","year":"2012","journal-title":"Mol. Ther."},{"key":"10.1016\/j.ymthe.2026.08.004_bib31","doi-asserted-by":"crossref","first-page":"1275","DOI":"10.1038\/sj.gt.3302092","article-title":"Gene therapy progress and prospects: gene therapy of lysosomal storage disorders","volume":"10","author":"Cheng","year":"2003","journal-title":"Gene Ther."},{"key":"10.1016\/j.ymthe.2026.08.004_bib32","doi-asserted-by":"crossref","first-page":"399","DOI":"10.1016\/j.omtm.2019.04.001","article-title":"Pre-clinical Safety and Efficacy of Lentiviral Vector-Mediated Ex Vivo Stem Cell Gene Therapy for the Treatment of Mucopolysaccharidosis IIIA","volume":"13","author":"Ellison","year":"2019","journal-title":"Mol. Ther. Methods Clin. Dev."},{"key":"10.1016\/j.ymthe.2026.08.004_bib33","doi-asserted-by":"crossref","DOI":"10.1038\/s41467-024-52400-8","article-title":"Ready-to-use iPSC-derived microglia progenitors for the treatment of CNS disease in mouse models of neuropathic mucopolysaccharidoses","volume":"15","author":"Douvaras","year":"2024","journal-title":"Nat. Commun."},{"key":"10.1016\/j.ymthe.2026.08.004_bib34","doi-asserted-by":"crossref","DOI":"10.1038\/s41421-022-00377-3","article-title":"Distinct phases of adult microglia proliferation: a Myc-mediated early phase and a Tnfaip3-mediated late phase","volume":"8","author":"Tan","year":"2022","journal-title":"Cell Discov."},{"key":"10.1016\/j.ymthe.2026.08.004_bib35","doi-asserted-by":"crossref","first-page":"639","DOI":"10.1111\/jnc.14632","article-title":"The role of innate immunity in mucopolysaccharide diseases","volume":"148","author":"Parker","year":"2019","journal-title":"J. Neurochem."},{"key":"10.1016\/j.ymthe.2026.08.004_bib36","doi-asserted-by":"crossref","first-page":"1999","DOI":"10.3390\/ijms23041999","article-title":"Innate Immunity in Mucopolysaccharide Diseases","volume":"23","author":"Mandolfo","year":"2022","journal-title":"Int. J. Mol. Sci."},{"key":"10.1016\/j.ymthe.2026.08.004_bib37","doi-asserted-by":"crossref","first-page":"152","DOI":"10.1101\/gad.1616208","article-title":"Human ES cell-derived neural rosettes reveal a functionally distinct early neural stem cell stage","volume":"22","author":"Elkabetz","year":"2008","journal-title":"Genes Dev."},{"key":"10.1016\/j.ymthe.2026.08.004_bib38","doi-asserted-by":"crossref","DOI":"10.15252\/emmm.201708730","article-title":"Brain-targeted stem cell gene therapy corrects mucopolysaccharidosis type II via multiple mechanisms","volume":"10","author":"Gleitz","year":"2018","journal-title":"EMBO Mol. Med."},{"key":"10.1016\/j.ymthe.2026.08.004_bib39","doi-asserted-by":"crossref","first-page":"1902","DOI":"10.1073\/pnas.252784899","article-title":"Activated microglia in cortex of mouse models of mucopolysaccharidoses I and IIIB","volume":"100","author":"Ohmi","year":"2003","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"10.1016\/j.ymthe.2026.08.004_bib40","doi-asserted-by":"crossref","first-page":"336","DOI":"10.1093\/brain\/awu355","article-title":"Neuroinflammation, mitochondrial defects and neurodegeneration in mucopolysaccharidosis III type C mouse model","volume":"138","author":"Martins","year":"2015","journal-title":"Brain."},{"key":"10.1016\/j.ymthe.2026.08.004_bib41","article-title":"Induced neural stem cells suppressed neuroinflammation by inhibiting the microglial pyroptotic pathway in intracerebral hemorrhage rats","volume":"26","author":"Liu","year":"2023","journal-title":"iScience"},{"key":"10.1016\/j.ymthe.2026.08.004_bib42","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1016\/S0304-3940(01)02331-X","article-title":"Grafting neural stem cells improved the impaired spatial recognition in ischemic rats","volume":"316","author":"Toda","year":"2001","journal-title":"Neurosci. Lett."},{"key":"10.1016\/j.ymthe.2026.08.004_bib43","doi-asserted-by":"crossref","first-page":"1657","DOI":"10.3727\/096368913X674648","article-title":"Transplantation of Enteric Neural Stem\/Progenitor Cells into the Irradiated Young Mouse Hippocampus","volume":"23","author":"Osman","year":"2014","journal-title":"Cell Transpl."},{"key":"10.1016\/j.ymthe.2026.08.004_bib44","article-title":"Dying transplanted neural stem cells mediate survival bystander effects in the injured brain","volume":"14","author":"Han","year":"2023","journal-title":"Cell Death Dis."},{"key":"10.1016\/j.ymthe.2026.08.004_bib45","doi-asserted-by":"crossref","first-page":"1836","DOI":"10.1038\/nprot.2012.116","article-title":"Directed differentiation of human pluripotent stem cells to cerebral cortex neurons and neural networks","volume":"7","author":"Shi","year":"2012","journal-title":"Nat. Protoc."},{"key":"10.1016\/j.ymthe.2026.08.004_bib46","doi-asserted-by":"crossref","first-page":"1289","DOI":"10.1093\/neuonc\/noaa051","article-title":"Actinomycin D downregulates Sox2 and improves survival in preclinical models of recurrent glioblastoma","volume":"22","author":"Taylor","year":"2020","journal-title":"Neuro. Oncol."},{"key":"10.1016\/j.ymthe.2026.08.004_bib47","doi-asserted-by":"crossref","DOI":"10.15252\/emmm.201911185","article-title":"Haematopoietic stem cell gene therapy with IL-1Ra rescues cognitive loss in mucopolysaccharidosis IIIA","volume":"12","author":"Parker","year":"2020","journal-title":"EMBO Mol. Med."},{"key":"10.1016\/j.ymthe.2026.08.004_bib48","doi-asserted-by":"crossref","first-page":"278","DOI":"10.1007\/BF01799255","article-title":"A fluorimetric enzyme assay for the diagnosis of sanfilippo disease type A (MPS IIIA)","volume":"19","author":"Karpova","year":"1996","journal-title":"J. Inherit. Metab. Dis."},{"key":"10.1016\/j.ymthe.2026.08.004_bib49","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0172435","article-title":"Identification of age-dependent motor and neuropsychological behavioural abnormalities in a mouse model of Mucopolysaccharidosis Type II","volume":"12","author":"Gleitz","year":"2017","journal-title":"PLOS ONE"},{"key":"10.1016\/j.ymthe.2026.08.004_bib50","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0025717","article-title":"Female Mucopolysaccharidosis IIIA Mice Exhibit Hyperactivity and a Reduced Sense of Danger in the Open Field Test","volume":"6","author":"Langford-Smith","year":"2011","journal-title":"PLoS ONE"},{"key":"10.1016\/j.ymthe.2026.08.004_bib51","doi-asserted-by":"crossref","first-page":"99","DOI":"10.1093\/brain\/awx311","article-title":"Macrophage enzyme and reduced inflammation drive brain correction of mucopolysaccharidosis IIIB by stem cell gene therapy","volume":"141","author":"Holley","year":"2018","journal-title":"Brain."},{"key":"10.1016\/j.ymthe.2026.08.004_bib52","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0014192","article-title":"Genistein Improves Neuropathology and Corrects Behaviour in a Mouse Model of Neurodegenerative Metabolic Disease","volume":"5","author":"Malinowska","year":"2010","journal-title":"PLoS ONE"}],"container-title":["Molecular Therapy"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1525001626006854?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1525001626006854?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,9,6]],"date-time":"2026-09-06T04:22:18Z","timestamp":1788668538000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1525001626006854"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,8]]},"references-count":51,"alternative-id":["S1525001626006854"],"URL":"https:\/\/doi.org\/10.1016\/j.ymthe.2026.08.004","relation":{},"ISSN":["1525-0016"],"issn-type":[{"value":"1525-0016","type":"print"}],"subject":[],"published":{"date-parts":[[2026,8]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Human iPSC-derived neural progenitor gene therapy improves outcomes in a neuropathic lysosomal disease","name":"articletitle","label":"Article Title"},{"value":"Molecular Therapy","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ymthe.2026.08.004","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2026 The Authors. Published by Elsevier Inc. on behalf of The American Society of Gene and Cell Therapy.","name":"copyright","label":"Copyright"}]}}